SCHEMBL20249642

SCHEMBL20249642

Cc1c2c(-c3ccc(-c4ccncc4)cc3)nc3ccccc3c2c(C)c2c(-c3ccc(-c4ccncc4)cc3)nc3ccccc3c12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 4/20 0.49
MAPK14 Q16539 4/20 0.49
MAPK10 P53779 1/20 0.49
TDP1 Q9NUW8 1/20 0.45
TSHR P16473 1/20 0.44
PDE10A Q9Y233 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
MAPT P10636 2/20 0.43
HSP90AA1 P07900 1/20 0.43
NOTUM Q6P988 1/20 0.42
ALDH1A1 P00352 2/20 0.42
MAPK13 O15264 2/20 0.42
MAPK12 P53778 2/20 0.42
MAPK11 Q15759 2/20 0.42
KDM4E B2RXH2 1/20 0.42
ADORA2A P29274 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
MKNK1 Q9BUB5 1/20 0.41
RAF1 P04049 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20245110 0.92 DHODH (0.46) DHODHMAPK14MAPK10TDP1TSHR
SCHEMBL20245041 0.92 DHODH (0.46) DHODHMAPK14MAPK10TDP1TSHR
SCHEMBL20249629 0.89 DHODH (0.44) DHODHMAPK14MAPK10TDP1TSHR
SCHEMBL20249662 0.88 MKNK1 (0.47) DHODHMAPK14MAPK10TDP1MEN1
SCHEMBL20249678 0.88 DHODH (0.42) DHODHMAPK14TSHRPDE10AMEN1
SCHEMBL20249686 0.87 MEN1 (0.43) DHODHMAPK14MAPK10MEN1KMT2A
SCHEMBL20245140 0.86 DHODH (0.43) DHODHMAPK14MAPK10TDP1TSHR
SCHEMBL20249700 0.86 MEN1 (0.44) DHODHMAPK14MAPK10MEN1KMT2A
SCHEMBL20245107 0.85 DHODH (0.49) DHODHTDP1TSHRPDE10AMEN1
SCHEMBL20249633 0.85 MAPK14 (0.52) DHODHMAPK14MAPK10ALDH1A1MAPK13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10693083-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-06-23 US disclosed
US-20180166635-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-06-14 US disclosed
US-20180166635-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180166635-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 DHODH 1907/4885MAPK14 3927/4885MAPK10 3816/4885
US-10693083-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 DHODH 1907/4885MAPK14 3927/4885MAPK10 3816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.